Your browser doesn't support javascript.
Severe Acute Respiratory Syndrome Coronavirus 2 Infections Among Children in the Biospecimens from Respiratory Virus-Exposed Kids (BRAVE Kids) Study.
Hurst, Jillian H; Heston, Sarah M; Chambers, Hailey N; Cunningham, Hannah M; Price, Meghan J; Suarez, Lilianna; Crew, Carter G; Bose, Shree; Aquino, Jhoanna N; Carr, Stuart T; Griffin, S Michelle; Smith, Stephanie H; Jenkins, Kirsten; Pfeiffer, Trevor S; Rodriguez, Javier; DeMarco, C Todd; De Naeyer, Nicole A; Gurley, Thaddeus C; Louzao, Raul; Zhao, Congwen; Cunningham, Coleen K; Steinbach, William J; Denny, Thomas N; Lugo, Debra J; Moody, M Anthony; Permar, Sallie R; Rotta, Alexandre T; Turner, Nicholas A; Walter, Emmanuel B; Woods, Christopher W; Kelly, Matthew S.
  • Hurst JH; Department of Pediatrics, Division of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina, USA.
  • Heston SM; Children's Health and Discovery Institute, Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA.
  • Chambers HN; Department of Pediatrics, Division of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina, USA.
  • Cunningham HM; Duke University School of Medicine, Durham, North Carolina, USA.
  • Price MJ; Duke University School of Medicine, Durham, North Carolina, USA.
  • Suarez L; Duke University School of Medicine, Durham, North Carolina, USA.
  • Crew CG; Duke University School of Medicine, Durham, North Carolina, USA.
  • Bose S; Children's Health and Discovery Institute, Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA.
  • Aquino JN; Duke University School of Medicine, Durham, North Carolina, USA.
  • Carr ST; Department of Pediatrics, Division of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina, USA.
  • Griffin SM; Department of Pediatrics, Division of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina, USA.
  • Smith SH; Children's Clinical Research Unit, Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA.
  • Jenkins K; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA.
  • Pfeiffer TS; Department of Pediatrics, Division of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina, USA.
  • Rodriguez J; Department of Pediatrics, Division of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina, USA.
  • DeMarco CT; Children's Clinical Research Unit, Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA.
  • De Naeyer NA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA.
  • Gurley TC; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA.
  • Louzao R; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA.
  • Zhao C; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA.
  • Cunningham CK; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina, USA.
  • Steinbach WJ; Department of Pediatrics, Division of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina, USA.
  • Denny TN; Department of Pediatrics, Division of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina, USA.
  • Lugo DJ; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA.
  • Moody MA; Department of Pediatrics, Division of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina, USA.
  • Permar SR; Department of Pediatrics, Division of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina, USA.
  • Rotta AT; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA.
  • Turner NA; Department of Pediatrics, Division of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina, USA.
  • Walter EB; Children's Health and Discovery Institute, Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA.
  • Woods CW; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA.
  • Kelly MS; Department of Pediatrics, Division of Pediatric Critical Care Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
Clin Infect Dis ; 73(9): e2875-e2882, 2021 11 02.
Article in English | MEDLINE | ID: covidwho-1501033
ABSTRACT

BACKGROUND:

Child with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection typically have mild symptoms that do not require medical attention, leaving a gap in our understanding of the spectrum of SARS-CoV-2-related illnesses that the viruses causes in children.

METHODS:

We conducted a prospective cohort study of children and adolescents (aged <21 years) with a SARS-CoV-2-infected close contact. We collected nasopharyngeal or nasal swabs at enrollment and tested for SARS-CoV-2 using a real-time polymerase chain reaction assay.

RESULTS:

Of 382 children, 293 (77%) were SARS-CoV-2-infected. SARS-CoV-2-infected children were more likely to be Hispanic (P < .0001), less likely to have asthma (P = .005), and more likely to have an infected sibling contact (P = .001) than uninfected children. Children aged 6-13 years were frequently asymptomatic (39%) and had respiratory symptoms less often than younger children (29% vs 48%; P = .01) or adolescents (29% vs 60%; P < .001). Compared with children aged 6-13 years, adolescents more frequently reported influenza-like (61% vs 39%; P < .001) , and gastrointestinal (27% vs 9%; P = .002), and sensory symptoms (42% vs 9%; P < .0001) and had more prolonged illnesses (median [interquartile range] duration 7 [4-12] vs 4 [3-8] days; P = 0.01). Despite the age-related variability in symptoms, wWe found no difference in nasopharyngeal viral load by age or between symptomatic and asymptomatic children.

CONCLUSIONS:

Hispanic ethnicity and an infected sibling close contact are associated with increased SARS-CoV-2 infection risk among children, while asthma is associated with decreased risk. Age-related differences in clinical manifestations of SARS-CoV-2 infection must be considered when evaluating children for coronavirus disease 2019 and in developing screening strategies for schools and childcare settings.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Limits: Adolescent / Child / Humans Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: Cid

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Limits: Adolescent / Child / Humans Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: Cid